ICMR Study Finds No Link between COVID Vaccine and Sudden Deaths

Union Health Minister J P Nadda informed the Lok Sabha on Friday that an ICMR study had shown that the Covid vaccine did not raise the risk of sudden, unexplained deaths among young adults in India

Tulsi Therapeutics Develops Stem Cell Cure for Chronic Liver Failure

A potential stem cell treatment for chronic liver failure was successfully evaluated by a startup based at the University of Hyderabad (UoH). The company claims that the treatment, known as Tulsi-28X, is the first in the world to employ a unique

Lupin Gets USFDA Nod for Liraglutide, Glucagon Injectables

Approval has been received by Lupin Limited from the United States Food and Drug Administration for its Abbreviated New Drug Applications for Liraglutide Injection Single-Patient-Use Prefilled Pens and Glucagon for Injection vials...

Apollo and Siemens Join Forces to Revolutionize Liver Healthcare with AI

Apollo Hospitals and Siemens Healthineers are poised to redefine the diagnosis and treatment of liver disease. The two have announced a collaboration to innovate advanced clinical liver healthcare through the use of AI-enabled imaging...

Cipla invests in iCaltech to boost respiratory health portfolio

Cipla Limited said that it entered into definitive agreements to invest in iCaltech Innovations Private Limited by Optionally Convertible Preference Shares.

DBT Launches AI-Backed Image Biobanks to Boost Diagnostics

The Department of Biotechnology (DBT) has released a flagship program for establishing a countrywide network of artificial intelligence

ADIA Invests USD 200 Million in India's Meril to Boost MedTech Growth

In an important development demonstrating confidence in the global healthcare sector of India, Abu Dhabi Investment Authority (ADIA) has completed a definitive investment agreement for USD 200 million in Meril, a high-quality medical device company..

SuanNutra's Gonmisol Ties Up with K Patel to Bring Ayurvedic Extracts to Europe

In a significant step to enhance its natural health portfolio, SuanNutra Group's European distribution division Gonmisol has signed an exclusive distribution agreement with Indian-based K Patel Phyto Extractions...

FDA Rejects Roche's Bid for Columvi Combo in Early-Line DLBCL

Roche faced a regulatory setback today as the U.S. FDA issued a Complete Response Letter (CRL) for its bid to expand Columvi (glofitamab) in combination with gemcitabine and oxaliplatin (GemOx) for certain DLBCL patients...

Clinical trials support ILUMYA for psoriatic arthritis

Top-line findings from two Phase 3 clinical trials assessing the safety and effectiveness of tildrakizumab 100 mg (ILUMYA) given over a 24-week period for the treatment of active psoriatic arthritis were released today by Sun Pharmaceutical

on the deck

Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.